Langguth P, Lee K M, Spahn-Langguth H, Amidon G L
College of Pharmacy, University of Michigan, Ann Arbor 48109.
Biopharm Drug Dispos. 1994 Dec;15(9):719-46. doi: 10.1002/bdd.2510150902.
The influence of various fasting-state gastrointestinal parameters on variability in absorption of cimetidine was studied using simulation and cimetidine administration as a duodenal infusion and as an oral tablet in fistulated mongrel dogs. In the simulation studies, the frequency of double-peak occurrence in plasma profiles was estimated employing average gastric emptying rates as well as interdigestive-migrating-motor-complex (IMMC) phase lengths that were systematically altered. Emptying rates and phase lengths were modeled as periodic step functions. Simulations indicated that double peaks occur when gastric emptying of the drug begins in early phase I or late phase II/III, which represent the periods of very low, medium, and high gastrointestinal motility, respectively. The incidence is increased for longer phase-I duration and higher elimination rate constants. For a compound with a 2 h elimination or disposition half-life, two concentration maxima (double peaks) were found in 12% of the simulated concentration-time profiles. The double peak frequency in simulated curves was considerably higher for t1/2 < 30 min. When cimetidine was administered to dogs as a duodenal infusion in the active and quiescent motility phases, discontinuous profiles were observed, although the variability of the various parameters was reduced when compared. Pharmacokinetic models were set up that were characterized by multi-segmental input (one- to 3-lag-time models were used) for the profiles resulting from oral and duodenal administration. The lag time for the first process characterized the onset of absorption. A significant difference between phases was detected for infusions at pH 8, where the initial lag time was longer in the quiescent phase. The mean input time (MIT) was calculated as the integral input parameter. There was a tendency for the MIT to be higher for pH 6 infusions than for pH 4 and pH 8. Bioavailability analysis indicated that cimetidine was more rapidly and completely absorbed at pH 8 than at pH 6. Bioavailability was also slightly higher at pH 4 than at pH 6. We concluded that gastric emptying increased the variability of the cimetidine concentration-against-time profiles and that it plays a role with respect to double-peak occurrence, although it is only one of several causative factors.
利用模拟以及在瘘管杂种犬中以十二指肠灌注和口服片剂形式给予西咪替丁,研究了各种禁食状态下的胃肠道参数对西咪替丁吸收变异性的影响。在模拟研究中,采用平均胃排空率以及系统改变的消化间期移行性复合运动(IMMC)相长度来估计血浆浓度曲线中双峰出现的频率。排空率和相长度被建模为周期性阶跃函数。模拟表明,当药物的胃排空在I期早期或II/III期晚期开始时会出现双峰,这两个时期分别代表胃肠道极低、中等和高运动性的时期。I期持续时间越长且消除速率常数越高,双峰发生率越高。对于消除或处置半衰期为2小时的化合物,在12%的模拟浓度-时间曲线中发现了两个浓度最大值(双峰)。当t1/2<30分钟时,模拟曲线中的双峰频率显著更高。当在活跃和静止运动期以十二指肠灌注形式给犬给予西咪替丁时,观察到了不连续的曲线,尽管相比之下各种参数的变异性有所降低。建立了药代动力学模型,其特征在于针对口服和十二指肠给药产生的曲线采用多段输入(使用一至三个滞后时间模型)。第一个过程的滞后时间表征吸收的开始。在pH 8时进行灌注,各期之间检测到显著差异,其中静止期的初始滞后时间更长。平均输入时间(MIT)作为积分输入参数进行计算。pH 6灌注的MIT有高于pH 4和pH 8灌注的趋势。生物利用度分析表明,西咪替丁在pH 8时比在pH 6时吸收更快且更完全。在pH 4时的生物利用度也略高于pH 6。我们得出结论,胃排空增加了西咪替丁浓度-时间曲线的变异性,并且它在双峰出现方面起作用,尽管它只是几个致病因素之一。